medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2014, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (1)

A case of porphyria cutanea tarda of multifactorial etiology

Rodríguez ZNJ, Mancheno VA, Arenas R, Fuentes SA, Díaz GJM, Lacy NRM, Toussaint CS

Language: Spanish
References: 18
Page: 37-40
PDF size: 150.43 Kb.


ABSTRACT

Case report a 49 year-old man with congenital solitary kidney and extensive pathological background, who developed a skin condition characterized by multiple vesicles, ulcerations and linear scars in exposed areas.
Biopsy and increased urinary levels of porphyrins confirmed the diagnosis of porphyria cutanea tarda of multifactorial origin.


REFERENCES

  1. Sassa S. “Modern diagnosis and management of the porphyrias”. Br J Dermatol 2006; 135: 281-292.

  2. Kauppinen R. “Porphyrias”. Lancet 2005; 365: 241-252.

  3. Arenas R, Dermatología Atlas, diagnóstico y tratamiento, 4ª ed., México, McGraw-Hill, 2009, pp. 241-248.

  4. Frank J, Poblete-Gutiérrez P. “Porphyria”. En: Bolognia J, Jorizzo J, Rapini R. Dermatology. 2ª ed. España, Mosby Elsevier, 2008: 641-644.

  5. Kappas A, Sassa S, Galbraith RA. “The porphyrias”. En: The metabolic and molecular basis of inherited disease. Nueva York, McGraw-Hill, 1995: 2103-2159.

  6. Frank J, Christiano AM. “The genetic bases of the porphyrias”. Skin Pharmacol Appl Skin Physiol 1998; 11: 297-309.

  7. Felsher BF, Carpio NM, Engleking DW, Nunn AT. “Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda”. N Engl J Med 1982; 306: 766-769.

  8. Fevang S, Kroon S, Skadberg O. “Pseudoporphyria or Porphyria Cutanea Tarda? Diagnostic and Treatment Difficulties”. Acta Derm Venereol 2008; 88(4): 426-427.

  9. Pérez L, Fernández-Redondo V, Toribio J. “Porfiria cutánea tarda en una paciente hemodializada”. Actas Dermosifiliogr 2006; 97(2): 115-117.

  10. Labidi J. “Porphyria cutanea tarda in a chronic hemodialysis patient”. Saudi J Kidney Dis Transpl 2010; 21: 919-922.

  11. Bickers D, Frank J, “Porfiria”. En: Fitzpatrick’s Dermatology in General Medicine, 7ª ed. Nueva York , Mc Graw-Hill, 2008: 1228-1242

  12. Dombeck TA, Satonik R. “The porphyrias”. Emerg Med Clin North Am 2005; 23(3): 885-899.

  13. Kolanko E, Bickle K, Keehn C, Glass LF. “Subepidermal blistering disorders: a clinical and histopathologic review”. Semin Cutan Med Surg 2004; 23: 10-18.

  14. Vadoud-Seyedi J, Dobbeleer G, Simonart T. “Treatment of haemodialysis- associated pseudoporphyria with N- acetylcysteine: report of two cases”. Br J Dermatol 2000; 142: 580-540.

  15. Schanbacher CF, Vanness ER, Daoud MS, Tefferi A, Daniel Su WP. “Pseudoporphyria: a clinical and biochemical study of 20 patients”. Mayo Clin Proc. 2001; 76: 488-492.

  16. Köstler E, Wollina U. “Therapy of porphyria cutanea tarda”. Expert Opin Pharmacother 2005; 6(3): 377-383.

  17. Peces R, Enríquez de Salamanca R, Fontenellas A, et al. “Successful treatment of haemodialysisrelated porphyria cutanea tarda with erythropoietin”. Nephrol Dial Transplant 1994; 9: 433-435.

  18. Pitche P, Corrin E, Wolkenstein P, Revuz J, Bagot M. “Successful treatment of hemodialysisrelated porphyria cutanea tarda with deferoxamine”. Ann Dermatol Venereol 2003s; 130: 37-39.




2020     |     www.medigraphic.com